16th Jan 2015 07:46
LONDON (Alliance News) - Avacta Group PLC on Friday said it has signed a deal with Swedish protein sciences company Agrisera AB to develop Affirmer-based purification systems for proteomics applications.
Avacta, a healthcare diagnostics business, did not provide any financial information on the agreement but said the deal would provide for commercialisation of the applications to be handled by Agrisera in an undisclosed revenue-sharing model.
Affimers are an engineered alternative to antibodies. They have advantages over antibodies in this depletion application because of their small size, leading to higher packing density and therefore greater capacity of the depletion system, lower manufacturing cost, greater stability and robustness, Avacta said.
"Agrisera are a well respected, high quality provider of research tools for plant sciences research and I am delighted that we will be working with them to develop the first Affimer based product for the agri-bio market," said Avacta Chief Executive Officer Alastair Smith.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
Avacta Group